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Abstract
Introduction: The goal of non-operative management (NOM) for blunt splenic trauma (BST) is to preserve the
spleen. The advantages of NOM for minor splenic trauma have been extensively reported, whereas its value for the
more severe splenic injuries is still debated. The aim of this systematic review was to evaluate the available
published evidence on NOM in patients with splenic trauma and to compare it with the operative management
(OM) in terms of mortality, morbidity and duration of hospital stay.
Methods: For this systematic review we followed the “Preferred Reporting Items for Systematic Reviews and
Meta-analyses” statement. A systematic search was performed on PubMed for studies published from January 2000
to December 2011, without language restrictions, which compared NOM vs. OM for splenic trauma injuries and
which at least 10 patients with BST.
Results: We identified 21 non randomized studies: 1 Clinical Controlled Trial and 20 retrospective cohort studies
analyzing a total of 16,940 patients with BST. NOM represents the gold standard treatment for minor splenic
trauma and is associated with decreased mortality in severe splenic trauma (4.78% vs. 13.5% in NOM and OM,
respectively), according to the literature. Of note, in BST treated operatively, concurrent injuries accounted for the
higher mortality. In addition, it was not possible to determine post-treatment morbidity in major splenic trauma.
The definition of hemodynamic stability varied greatly in the literature depending on the surgeon and the trauma
team, representing a further bias. Moreover, data on the remaining analyzed outcomes (hospital stay, number of
blood transfusions, abdominal abscesses, overwhelming post-splenectomy infection) were not reported in all
included studies or were not comparable, precluding the possibility to perform a meaningful cumulative analysis
and comparison.
Conclusions: NOM of BST, preserving the spleen, is the treatment of choice for the American Association for the
Surgery of Trauma grades I and II. Conclusions are more difficult to outline for higher grades of splenic injury,
because of the substantial heterogeneity of expertise among different hospitals, and potentially inappropriate
comparison groups.
Introduction
Trauma is the fourth cause of death in the overall popu-
lation and the first one in individuals below the age of
40 in Western countries [1,2]. Abdominal trauma can
be classified as blunt or penetrating according to the
agent and its mechanism of action [1-3].
The spleen is the most frequently injured organ in
abdominal blunt trauma, mainly because of its highly vas-
cularized parenchyma and its anatomic location. Spleen is
the only structure involved in almost 46% of blunt trauma
(BT). On the other hand the liver (41.7%), kidneys (16.4%),
mesentery (15.1%), small and large bowel (10.1% and 6.3%,
respectively), pancreas (5%) and omentum may concur
with splenic injuries in the remaning part of BT [1,2].
Splenectomy was the only treatment proposed for
splenic trauma until the 1960s. In 1968, Upadhyaya and
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Simpson proposed Non-Operative Management (NOM)
in a study on 52 pediatric patients with splenic
trauma [4].
The ultimate goal of NOM is to preserve the spleen
and it is based on specific principles and criteria. NOM
procedures include conservative medical treatment and
angioembolization (AE) without access to the peritoneal
cavity. Advantages of NOM for minor splenic trauma
(grades I and II according to the American Association
for the Surgery of Trauma-AAST), have been extensively
reported, whereas its value for severe splenic injuries
(AAST grades IV and V) is still under debate [2-4]. The
aim of this systematic review was to evaluate the avail-
able published evidence on NOM in patients with
splenic trauma and to compare it with operative man-
agement (OM) in terms of mortality, morbidity and
duration of hospital stay.
Methods
The criteria of the “Preferred Reporting Items for Sys-
tematic Reviews and Meta-analyses (PRISMA) state-
ment” were followed in this systematic review [5].
Inclusion criteria
We analyzed randomized controlled trials (RCTs) and
non-randomized controlled studies (non-RCSs) compar-
ing NOM vs. OM for blunt splenic trauma (BST). Only
studies with at least 10 patients with BST were included.
No language restrictions were imposed.
Exclusion criteria
Studies were excluded if they involved only penetrating
splenic trauma or if respective numbers of penetrating
and blunt trauma were not specified.
Participants
Participants were patients of all ages and either gender
who had BST.
Type of intervention
The intervention types were NOM (clinical observation,
medical treatment and proximal or distal splenic
angioembolization) vs. OM (total or partial splenectomy,
splenorrhaphy, application of hemostatic agents).
Sources of information
The following shows the systematic search performed
on PubMed for papers published from January 2000 to
December 2011:
- non[All Fields] AND operative[All Fields] AND
("therapy"[Subheading] OR “therapy"[All Fields] OR
“treatment"[All Fields] OR “therapeutics"[MeSH
Terms] OR “therapeutics"[All Fields]) AND
("spleen"[MeSH Terms] OR “spleen"[All Fields] OR
“splenic"[All Fields])
- non[All Fields] AND operative[All Fields] AND
("organization and administration"[MeSH Terms]
OR ("organization"[All Fields] AND “administratio-
n"[All Fields]) OR “organization and administratio-
n"[All Fields] OR “management"[All Fields] OR
“disease management"[MeSH Terms] OR ("disea-
se"[All Fields] AND “management"[All Fields]) OR
“disease management"[All Fields]) AND ("spleen"
[MeSH Terms] OR “spleen"[All Fields] OR “splenic"[All
Fields]).
Collection of data
We developed a data collection sheet, including names
of authors, type of study, number of patients, type of
treatment (NOM vs. OM) and the number of patients
per treatment arm, mean age, Injury Severity Score
(ISS), blood pressure, gender, American Association for
the Surgery of Trauma (AAST) grade of splenic injury.
Two authors (RC, ST) extracted data from included stu-
dies according to the data collection sheet, while
another author (CB) oversaw the process. Controversies
were solved by involving a fourth author (GN).
Outcomes of interest
The primary endpoint of this systematic review was
considered the overall mortality defined as any death
that occurred after the start of NOM or OM and during
the hospital stay.
Secondary endpoints were overall morbidity, over-
whelming post-splenectomy infection (OPSI)/quality of
life, blood transfusion, abdominal abscesses and length
of hospital stay.
Statistical analysis
Two authors performed the statistical analysis according
to the PRISMA and the “Cochrane Handbook for Sys-
tematic Reviews” guidelines. Odds ratios (OR), (that is,
the possibility that an event occurs in the two groups of
treatment) were calculated for dichotomous outcomes
while a weighted mean difference (WMD) was calcu-
lated to summarize the continuous outcomes. The Man-
tel-Haenszel method was used to combine OR for
outcomes of interest. We also verified homogeneity
among the studies by calculating the Chi² and the
inconsistency (I²). As I² detected absence of homogene-
ity (>50%), the fixed effect model could not be used,
and we, therefore, used the random effect model for
analysis. Statistical analysis was conducted using the sta-
tistical software Review Manager Version 5.0 (The Nor-
dic Cochrane Centre, The Cochrane Collaboration,
2008, Copenhagen, Denmark).
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Study selection
Five hundred ninety-four studies were identified from
our literature search. After review of titles and abstracts,
12 studies were excluded because of overlapping data
and 495 because they were not relevant to the aims of
our review. We analyzed the full texts of the 87 remain-
ing studies, 21 of them met the inclusion criteria, while
66 were excluded (Figure 1).
Search strategy results
We analyzed 21 non-randomized studies [1,6-25]: one
clinical controlled trial and 20 retrospective cohort stu-
dies analyzing a total of 16,940 patients with blunt sple-
nic injury (BSI); 12,449 underwent NOM vs. 4,491 OM
(Additional file 1: Table S1).
Quality of included studies
Quality of included studies was assessed by two authors
(CR and ST) using the Newcastle-Ottawa Scale (NOS)
[26] and is reported in Additional file 2: Table S2. All
included studies had good methodological quality
(>5 points) (mean 7.9 points, range 7 to 9).
Risk of bias
Mean age
Twenty studies [1,6-14,16-25] reported participants’ age:
mean value was specified in 17 studies [1,6-10,12,14,16-25],
the age range in one study [11] and median age in another
study [13]. Crawford et al. reported the age of the 36
patients in whom treatment failed [15]. Mean age was 8.5
± 5.2 years in the OM group and 9.2 ± 13 years in the
NOM group in the study by Jim et al. [20] and 70.4 ± 9.3
in the group studied by Siriratsivawong et al. [16]. Only
two studies [6,16] enrolled elderly patients, while in the
other studies (patients’ age was comprised between less
than 1 [11] and 53 years [14]) (Additional file 3: Table S3).
Distribution of ages was not homogeneous, so it was
not possible to compare studies according to this
parameter.
Hemodynamic stability
Only four studies [8,10,18,21] reported hemodynamic
characteristics of patients: Duchesne et al. and Dent et
al. [8,18] defined patients as hemodynamically stable
(HDS) if blood pressure was >100 mmHg. Scappellato
et al. and Wahl et al. [10,21] treated HDS patients
with NOM and hemodynamically unstable patients with
OM. Blood pressure values were reported only in
10 studies [9-11,13,17,18,20-22,24], seven studies
[9,10,16,18,20,22,24] reported the median systolic blood
pressure, two studies [11,13] reported the number of
patients with blood pressure above or below 90 mmHg
and one study [21] reported the mean systolic/diastolic
blood pressure. One study did not specify blood pres-
sure criteria for NOM or OM [9]. Two studies [11,13]
used the 90 mmHg cut-off without specifying how many
patients had blood pressure between 90 and 100 mmHg;
therefore, even hemodynamic unstable patients under-
went NOM (Additional file 3: Table S3).
Injury Severity Score (ISS)
ISS was reported in 19 studies: mean value was reported
in 3 studies [8,12,19], median value ± SD in 14 studies
[1,6,7,9,10,14,16-18,20,22-25], the range of ISS was
reported in 1 study [11], while in another study [13] ISS
was defined with values above or below a cut-off of 25.
It was possible to extrapolate the ISS value for the
patients in the two compared groups (NOM vs. OM)
from only one study [18], while Costa et al. [1], Claridge
et al. [25], Gaarder et al. [14] and Harbrecht et al. [9]
did not differentiate ISS values between NOM or OM.
Cochran et al. [7] and Tsugawa et al. [6] defined ISS for
pediatric or adult patients and for older patients, never-
theless without distinguishing between NOM and OM
(Additional file 3: Table S3).
AAST
AAST grades of splenic lesions were reported in 11 stu-
dies: the number of patients relative to each AAST was
reported in 6 studies [14,18,20-22], the mean AAST of
NOM and OM groups were reported in 5 studies
[6,10,16,23,24], and percentage of patients relative to
AAST was reported in 1 study [25] (Additional file 3:
Table S3).
Diagnostic protocol for BST
Thirteen studies reported a specific diagnostic algorithm
for abdominal trauma management [1,10,11,13-18,
21,23-25], while five studies [7,9,12,19,22] did not (Addi-
tional file 4: Table S4).
Figure 1 Search strategy.
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Imaging
Only one study [21] described the use of ultrasound,
while others reported the use of only computed tomogra-
phy (CT) of the abdomen (Additional file 4: Table S4).
Results
Overall mortality
Only three studies [18,20,22] reported the mortality rela-
tive to the AAST grading of splenic injuries. In particu-
lar, the mortality rate in patients with grades I and II of
splenic injuries treated with NOM was 0%, but it was
not possible to confirm the grading in patients with
minor splenic injuries treated with OM since they did
never required surgery [18,20,22]. The mortality in
patients with grade III injuries was reported only by
Duchesne et al. [18] and was similar in the two treat-
ment groups (16% vs. 23% in NOM and OM, respec-
tively). In patients with grades IV and V of splenic
injuries the mortality was analyzed and reported in
three studies [18,20,22]; mortality was lower in OM
than in the NOM groups (mean rate 5.4% (45/337) vs.
13.3% (29/534), respectively). Data on the injuries of
grade V was available only in the studies by Duchense
et al., this was not possible from the studies by Jim et
al. [20] and Velmahos et al. [22]. In fact, Duchesne et
al. [18] distinguished mortality in grades IV and V
(mean rate 31.5% vs. 13.7% in NOM and OM for grade
IV - 12.5% vs. 66.6% in NOM and OM for grade V,
respectively). Gaarder et al. [14] and Scappellato et al.
[21], on the other hand, did not report the mortality
with respect to the grade of lesion nor to treatment.
(Additional file 5: Table S5).
Overall morbidity
Only three studies [10,18,22] compared morbidity in the
NOM and OM groups; six studies [6,8,12,14,15,21]
reported data on morbidity but did not distinguish
between the two treatment groups. In those three stu-
dies [10,18,22], it was possible to analyze morbidity
according to the classification of Dindo-Clavien (DC)
(Additional files 6, 7, 8: Tables S6-S8). Among 78
patients that underwent OM, 7 presented AAST grade
III lesions. Of these, three had DC grade IV and four
patients had DC grade V complications; in eight patients
with AAST grade IV, two had DC grade IV and six had
DC grade V complications. Among seven patients with
AAST grade V, three had DC grade IV and four had
DC grade V complications. Of the 76 patients who
underwent NOM, 1 patient presented a AAST grade I
lesion and a DC grade IV complication; 3 patients with
AAST grade II had DC grade IV complications. Twelve
patients had AAST grade III lesions, seven of whom had
a DC grade IV while five had DC grade V complica-
tions. Among 15 patients with AAST grade IV lesions,
11 had DC grade IV and 4 had DC grade V complica-
tions. Among six patients with AAST grade V lesions,
four had DC grade IV while two had DC grade V
complications.
Overwhelming post-splenectomy infection (OPSI)/quality
of life
None of the included studies reported post-operative
follow-up. For this reason, it was not possible to calcu-
late the incidence of OPSI or quality of life after the
treatment.
Blood transfusion
Only seven studies [10,13-15,18,19,24] reported the
number of blood transfusions (Additional file 9: Table
S9). Only one study [24] reported the number of
patients who received blood transfusions with respect to
the type of treatment, specifying the number of patients
who received more than one transfusion: 19/31 in the
NOM group vs. 14/15 in the OM group.
Abdominal abscesses
Only two studies [6,14] reported the incidence of
abdominal abscesses, without specifying the method
used for their detection. Furthermore, the authors did
not specify in which group (NOM vs. OM) abscesses
occurred and in how many cases they were associated
with sepsis (Additional file 10: Table S10).
Hospital stay
Duration of hospital stay was reported in 11 studies
[6,7,9,12-14,16,18,20,22,25]. Only four studies [13,16,
20,25] distinguished results between the two groups
(NOM vs. OM). Claridge et al. [25] reported a median
value ± SD (Additional file 11: Table S11).
The analysis of subgroups according to the DC classi-
fication and AAST grading for splenic trauma was pos-
sible only in the study by Duchesne et al. [18] (see
Additional files 6 and 12, Tables S6 and S12). Among
76 patients that underwent NOM, 1 patient presented a
AAST grade I lesion and was classed DC grade IV; in 2
patients, AAST grade II lesions were associated with DC
grade IV complications. Twelve patients had AAST
grade III lesions, seven of whom had DC grade IV while
five had DC grade V complications. Among 15 patients
with AAST grade IV lesions, 11 had DC grade IV and 4
had DC grade V complications. Among six patients with
AAST grade V injury, four had DC grade IV and two
had DC grade V complications. Among 78 patients that
were treated with OM, 7 had AAST grade III injuries.
Three of these patients had DC grade IV and four had
DC grade V complications. Among eight patients with
AAST grade IV lesions, two had DC grade IV and six
had DC grade V complications. Among seven patients
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with AAST grade V, three had DC grade IV and four
DC grade V complications. Overall, hospital stay in the
NOM group was shorter than in OM, even if some stu-
dies reported a longer hospital stay in NOM because of
more lasting monitoring and later return to daily activ-
ities [12,15].
Discussion
In our systematic review, NOM represented the gold
standard treatment for AAST grades I and II in 21 non-
randomized studies (Additional file 1: Table S1) and was
associated with decreased mortality in severe splenic
trauma (AAST grades III to V) (4.78% vs. 13.5% in
NOM and OM, respectively) (Additional file 5: Table
S5) [20,22]. Mortality in OM group was higher, even if
splenic bleeding was not always indicated as the single
cause of death. In severe splenic trauma, it was not pos-
sible to determine post-treatment morbidity [10,18,22].
Furthermore, we could not establish which one of the
treatments was more beneficial in terms of other ana-
lyzed outcomes (hospital stay and number of blood
transfusions), since results either were not comparable
among the studies or they were not reported [19,27-35].
In the past, the gold standard treatment for minor
splenic lesions was early splenectomy [36-38], in order
to avoid fatal hemorrhage [20,35,39]. Gradually, due to
wider knowledge of the role and functions of the spleen,
more surgeons preferred a conservative approach, either
partial splenic salvage or NOM when possible
[8,14,23,29,31,33,39-43]. NOM is a complex, multidisci-
plinary strategy that starts with careful clinical observa-
tion and constant strict monitoring by means of
repeated laboratory tests and radiological imaging. Mod-
ern imaging techniques, such as multi-slice CT and con-
trast-enhanced ultrasound, have improved the
quantitative definition of hemoperitoneum, evaluation of
extension of splenic lesions, active bleeding and pre-
sence of concurring lesions in polytrauma patients
[32,44-55].
At present, it appears that NOM can also be the first
line treatment in some cases of severe splenic trauma
(AAST grades III to V) when the decision between
NOM and OM depends on careful risk-benefit analysis
for each patient [10,31-33,56,57] as well as on the exper-
tise of the surgeon and of the multidisciplinary team of
the hospital.
Splenectomy is not exempt from intra-operative and
post-operative complications, such as thrombocytosis,
post-splenectomy infections, abdominal abscess and
OPSI [59-61]. For these reasons, surgeons have pre-
ferred avoiding splenectomy. Nevertheless, the main risk
of NOM is the possibility of sudden delayed hemorrhage
that could be immediately fatal, before emergency sur-
gery can be performed [1,8-11,14-17,20,22,24]. In
addition, in NOM, the higher amounts of blood transfu-
sion that are often required, thus increasing the risk of
blood-borne disease, such as hepatitis [10,13-15,18,
24,62], and the increased risk of not detecting other
intra-abdominal lesions [17,18,39,63], have to be consid-
ered with respect to OM.
Unfortunately, follow-up was not reported in the stu-
dies included in this analysis; therefore, it was not possi-
ble to evaluate long-term complications [23,58,56]. The
role and frequency of repeating imaging in the follow-
up of patients treated with conservative treatment are
still under debate [32,44-55]. Radiological imaging is
necessary during the initial phases of NOM in order to
evaluate eventual bleeding and abscess formation, and
later, in order to detect the development of pseudo-
aneurysms [18,32,44-55].
Clinical observation of the patient at the moment of
hospitalization and monitoring of clinical conditions
represent Ariadne’s thread that brings caretakers
through the labyrinth of laboratory and investigational
tests and finally to success (or failure) of NOM [64-69].
Conclusions
In conclusion, NOM has been accepted as standard
treatment for AAST grades I and II BST, whereas this
was not found to be safe in higher grades of splenic
trauma. Currently, there is no consensus in the manage-
ment of severe splenic trauma. Velmahos, a distin-
guished trauma surgeon [22], stated that “generalization
about the overall success rates of NOM, should not
represent severe blunt splenic injury”.
Unfortunately, this review does not clarify the contro-
versies regarding the safest therapeutic approach to
severe splenic trauma (AAST grades IV and V) because
of the selection bias in the recruitment of the NOM and
OM groups, as well as missing data and heterogeneity of
the studies included. Furthermore, all studies included in
our review were retrospective and none were randomized
due to the obvious difficulties in designing a randomized
study on NOM of trauma patients.
Given the substantial heterogeneity between levels of
expertise in the different hospitals, inclusion of patients
with concurrent injuries of other organs and potentially
inappropriate comparison groups the conclusions of the
review may not be reliable for severe splenic trauma
(AAST grades IV and V).
Key messages
- NOM has been accepted as standard treatment for
splenic trauma grades I and II.
- Advantages of NOM for the more severe splenic
injuries are still debated.
- This review does not clarify the controversies
regarding the safest treatment approach for severe
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splenic trauma because of the selection bias in the
recruitment of the NOM and OM groups, as well as
missing data and heterogeneity of the studies
included.
- NOM can also be the initial treatment in some
cases of severe splenic trauma when the decision
between NOM and OM depends on careful risk-
benefit analysis for each patient as well as on the
expertise of the surgeon and of the multidisciplinary
team of the hospital.
- The definition of hemodynamic stability varied
greatly in the literature.
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